<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="review-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medlit</journal-id><journal-title-group><journal-title xml:lang="ru">Гигиена и санитария</journal-title><trans-title-group xml:lang="en"><trans-title>Hygiene and Sanitation</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0016-9900</issn><issn pub-type="epub">2412-0650</issn><publisher><publisher-name>Federal Scientific Center of Hygiene named after F.F. Erisman</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.47470/0016-9900-2023-102-11-1224-1227</article-id><article-id custom-type="edn" pub-id-type="custom">pgrkfd</article-id><article-id custom-type="elpub" pub-id-type="custom">medlit-3533</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПРОФИЛАКТИЧЕСКАЯ ТОКСИКОЛОГИЯ И ГИГИЕНИЧЕСКОЕ НОРМИРОВАНИЕ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PREVENTIVE TOXICOLOGY AND HYGIENIC STANDARTIZATION</subject></subj-group></article-categories><title-group><article-title>Экспрессия генов CDKN1A, MDM2 и ATM как биомаркер токсического действия тяжёлых металлов (обзор литературы)</article-title><trans-title-group xml:lang="en"><trans-title>Expression of the CDKN1A, MDM2, and ATM genes as a biomarker of the toxic effect of heavy metals (literature review)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7029-3406</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шаихова</surname><given-names>Дарья Рамильевна</given-names></name><name name-style="western" xml:lang="en"><surname>Shaikhova</surname><given-names>Daria R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Науч. сотр. отдела молекулярной биологии и электронной микроскопии ФБУН «Екатеринбургский медицинский научный центр профилактики и охраны здоровья рабочих промышленных предприятий» Роспотребнадзора, 620014, Екатеринбург</p><p>e-mail: darya.boo@mail.ru</p></bio><bio xml:lang="en"><p>Research Scientist, Department of Molecular Biology and Electron Microscopy, Yekaterinburg Medical Research Center for Prophylaxis and Health Protection in Industrial Workers, Yekaterinburg, 620014, Russian Federation</p><p>e-mail: darya.boo@mail.ru</p></bio><email xlink:type="simple">darya.boo@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8794-7288</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Амромина</surname><given-names>Анна Михайловна</given-names></name><name name-style="western" xml:lang="en"><surname>Amromina</surname><given-names>Anna M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мл. науч. сотр. отдела молекулярной биологии и электронной микроскопии ФБУН «Екатеринбургский медицинский научный центр профилактики и охраны здоровья рабочих промышленных предприятий» Роспотребнадзора, 620014, Екатеринбург</p><p>e-mail: amrominaam@ymrc.ru</p></bio><email xlink:type="simple">amrominaam@ymrc.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4109-9268</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Берёза</surname><given-names>Иван Андреевич</given-names></name><name name-style="western" xml:lang="en"><surname>Bereza</surname><given-names>Ivan A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Науч. сотр. отдела молекулярной биологии и электронной микроскопии ФБУН «Екатеринбургский медицинский научный центр профилактики и охраны здоровья рабочих промышленных предприятий» Роспотребнадзора, 620014, Екатеринбург</p><p>e-mail: berezaia@ymrc.ru</p></bio><email xlink:type="simple">berezaia@ymrc.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФБУН «Екатеринбургский медицинский научный центр профилактики и охраны здоровья рабочих промпредприятий» Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Yekaterinburg Medical Research Center for Prophylaxis and Health Protection in Industrial Workers</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>13</day><month>12</month><year>2023</year></pub-date><volume>102</volume><issue>11</issue><fpage>1224</fpage><lpage>1227</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Шаихова Д.Р., Амромина А.М., Берёза И.А., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Шаихова Д.Р., Амромина А.М., Берёза И.А.</copyright-holder><copyright-holder xml:lang="en">Shaikhova D.R., Amromina A.M., Bereza I.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.rjhas.ru/jour/article/view/3533">https://www.rjhas.ru/jour/article/view/3533</self-uri><abstract><p>Разработка новых подходов, которые позволят дифференцировать широкий спектр токсических эффектов, поможет значительно улучшить оценку риска. Для понимания механизмов ответа на молекулярном уровне важно изучение экспрессии генов, отвечающих за репарацию ДНК, так как данный процесс является одним из ранних ответов на токсическое действие.</p><p>Цель исследования — обобщение имеющихся данных об экспрессии генов репарации (CDKN1A, MDM2 и ATM) в рамках токсического эффекта воздействия тяжёлых металлов.</p><p>Проведён систематический поиск для выявления исследований по заданной теме в электронных базах данных PubMed, Web of Science, eLIBRARY и Google Scholar. Для поиска использовались следующие ключевые слова: heavy metals, CDKN1A, MDM2, ATM, toxicity, DNA repair, gene expression. Поиск научных публикаций осуществлялся независимо тремя авторами, все найденные статьи проверялись и сравнивались для отсеивания дублирующихся статей. В данный обзор включено 50 литературных источников.</p><p>Анализ токсикогеномных исследований позволил выделить несколько генов для оценки токсичности тяжёлых металлов среди большого количества биомаркеров-кандидатов. Наиболее часто рассматриваемыми генами являются ген p21/CDKN1A, протоонкоген MDM2 и ген ATM.</p><sec><title>Ограничения исследования</title><p>Ограничения исследования. Ограничением данного обзора является рассмотрение изменения экспрессии лишь небольшого числа генов, отвечающих за репарацию ДНК.</p></sec><sec><title>Заключение</title><p>Заключение. Таким образом, экспрессия вышеперечисленных генов биомаркеров даёт детальную картину реакции биологической системы на воздействие вредных факторов и может применяться в рамках оценки токсического действия.</p></sec><sec><title>Участие авторов</title><p>Участие авторов. Все соавторы внесли равнозначный вклад в исследование и подготовку статьи к публикации, прочли и одобрили финальную версию перед публикацией.</p></sec><sec><title>Конфликт интересов</title><p>Конфликт интересов. Авторы декларируют отсутствие явных и потенциальных конфликтов интересов в связи с публикацией данной статьи.</p></sec><sec><title>Финансирование</title><p>Финансирование. Исследование не имело спонсорской поддержки.</p></sec><sec><title>Поступила</title><p>Поступила: 09.10.2023 / Принята к печати: 15.11.2023 / Опубликована: 08.12.2023</p></sec></abstract><trans-abstract xml:lang="en"><p>The development of new approaches enabling differentiation of a wide range of toxic effects can significantly improve risk assessment. To understand the response mechanisms at the molecular level, it is important to study the expression of genes responsible for DNA repair, since this process is one of the early responses to toxic effects.</p><p>The purpose of the study was to summarize available data on the expression of repair CDKN1A, MDM2, and ATM genes associated with toxic effects of exposure to heavy metals.</p><p>A systematic search was carried out to identify studies on a given topic in the PubMed, Web of Science, eLIBRARY and Google Scholar electronic databases using the following keywords: heavy metals, CDKN1A, MDM2, ATM, toxicity, DNA repair, and gene expression. The initial search for scientific publications was carried out independently by three authors; then all sources found were checked and compared to filter out duplicate papers. This review covers 50 literature sources.</p><p>The analysis of toxicogenome studies allowed us to identify several genes for assessing heavy metal toxicity among a large number of candidate biomarkers. The most commonly considered genes are the p21/CDKN1A gene, the MDM2 proto-oncogene, and the ATM gene.</p><sec><title>Limitations</title><p>Limitations. The review is limited to considering changes in the expression of only a small number of genes responsible for DNA repair.</p></sec><sec><title>Conclusion</title><p>Conclusion. The expression of the above biomarker genes provides a detailed picture of the response of a biological system to hazardous exposures and can be used as part of the assessment of toxic effects.</p></sec><sec><title>Contributions</title><p>Contributions. All co-authors made a significant contribution to the development of concept, research and preparation of the article, read and approved its final version before publication.</p></sec><sec><title>Conflict of interest</title><p>Conflict of interest. The authors declare no conflict of interest.</p></sec><sec><title>Acknowledgement</title><p>Acknowledgement. The study had no sponsorship.</p></sec><sec><title>Received</title><p>Received: October 9, 2023 / Accepted: November 15, 2023 / Published: December 8, 2023</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>экспрессия</kwd><kwd>биомаркер</kwd><kwd>тяжёлые металлы</kwd><kwd>репарация</kwd><kwd>токсичность</kwd></kwd-group><kwd-group xml:lang="en"><kwd>expression</kwd><kwd>biomarker</kwd><kwd>heavy metals</kwd><kwd>repair</kwd><kwd>toxicit</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Sakai R., Kondo C., Oka H., Miyajima H., Kubo K., Uehara T. Utilization of CDKN1A/p21 gene for class discrimination of DNA damage-induced clastogenicity. Toxicology. 2014; 315: 8–16. https://doi.org/10.1016/j.tox.2013.10.009</mixed-citation><mixed-citation xml:lang="en">Sakai R., Kondo C., Oka H., Miyajima H., Kubo K., Uehara T. Utilization of CDKN1A/p21 gene for class discrimination of DNA damage-induced clastogenicity. Toxicology. 2014; 315: 8–16. https://doi.org/10.1016/j.tox.2013.10.009</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Radhakrishnan S., Gierut J., Gartel A. Multiple alternate p21 transcripts are regulated by p53 in human cells. Oncogene. 2006; 25(12): 1812–5. https://doi.org/10.1038/sj.onc.1209195</mixed-citation><mixed-citation xml:lang="en">Radhakrishnan S., Gierut J., Gartel A. Multiple alternate p21 transcripts are regulated by p53 in human cells. Oncogene. 2006; 25(12): 1812–5. https://doi.org/10.1038/sj.onc.1209195</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Kriwacki R.W., Hengst L., Tennant L., Reed S.I., Wright P.E. Structural studies of p21Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: conformational disorder mediates binding diversity. Proc. Natl. Acad. Sci. USA. 1996; 93(21): 11504–9. https://doi.org/10.1073/pnas.93.21.11504</mixed-citation><mixed-citation xml:lang="en">Kriwacki R.W., Hengst L., Tennant L., Reed S.I., Wright P.E. Structural studies of p21Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: conformational disorder mediates binding diversity. Proc. Natl. Acad. Sci. USA. 1996; 93(21): 11504–9. https://doi.org/10.1073/pnas.93.21.11504</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Cazzalini O., Scovassi A.I., Savio M., Stivala L.A., Prosperi E. Multiple roles of the cell cycle inhibitor p21(CDKN1A) in the DNA damage response. Mutat. Res. 2010; 704(1–3): 12–20. https://doi.org/10.1016/j.mrrev.2010.01.009</mixed-citation><mixed-citation xml:lang="en">Cazzalini O., Scovassi A.I., Savio M., Stivala L.A., Prosperi E. Multiple roles of the cell cycle inhibitor p21(CDKN1A) in the DNA damage response. Mutat. Res. 2010; 704(1–3): 12–20. https://doi.org/10.1016/j.mrrev.2010.01.009</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Abbas T., Dutta A. p21 in cancer: intricate networks and multiple activities. Nat. Rev. Cancer. 2009; 9(6): 400–14. https://doi.org/10.1038/nrc2657</mixed-citation><mixed-citation xml:lang="en">Abbas T., Dutta A. p21 in cancer: intricate networks and multiple activities. Nat. Rev. Cancer. 2009; 9(6): 400–14. https://doi.org/10.1038/nrc2657</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Duensing A., Ghanem L., Steinman R.A., Liu Y., Duensing S. p21(Waf1/Cip1) deficiency stimulates centriole overduplication. Cell Cycle. 2006; 5(24): 2899–902. https://doi.org/10.4161/cc.5.24.3567</mixed-citation><mixed-citation xml:lang="en">Duensing A., Ghanem L., Steinman R.A., Liu Y., Duensing S. p21(Waf1/Cip1) deficiency stimulates centriole overduplication. Cell Cycle. 2006; 5(24): 2899–902. https://doi.org/10.4161/cc.5.24.3567</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Mantel C., Braun S.E., Reid S., Henegariu O., Liu L., Hangoc G., et al. p21(cip-1/waf-1) deficiency causes deformed nuclear architecture, centriole overduplication, polyploidy, and relaxed microtubule damage checkpoints in human hematopoietic cells. Blood. 1999; 93(4): 1390–8.</mixed-citation><mixed-citation xml:lang="en">Mantel C., Braun S.E., Reid S., Henegariu O., Liu L., Hangoc G., et al. p21(cip-1/waf-1) deficiency causes deformed nuclear architecture, centriole overduplication, polyploidy, and relaxed microtubule damage checkpoints in human hematopoietic cells. Blood. 1999; 93(4): 1390–8.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Kreis N.N., Sanhaji M., Rieger M.A., Louwen F., Yuan J. p21Waf1/ Cip1 deficiency causes multiple mitotic defects in tumor cells. Oncogene. 2013; 33(50): 5716–28. https://doi.org/10.1038/onc.2013.518</mixed-citation><mixed-citation xml:lang="en">Kreis N.N., Sanhaji M., Rieger M.A., Louwen F., Yuan J. p21Waf1/ Cip1 deficiency causes multiple mitotic defects in tumor cells. Oncogene. 2013; 33(50): 5716–28. https://doi.org/10.1038/onc.2013.518</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Badie C., Dziwura S., Raffy C., Tsigani T., Alsbeih G., Moody J., et al. Aberrant CDKN1A transcriptional response associates with abnormal sensitivity to radiation treatment. Br. J. Cancer. 2008; 98(11): 1845–51. https://doi.org/10.1038/sj.bjc.6604381</mixed-citation><mixed-citation xml:lang="en">Badie C., Dziwura S., Raffy C., Tsigani T., Alsbeih G., Moody J., et al. Aberrant CDKN1A transcriptional response associates with abnormal sensitivity to radiation treatment. Br. J. Cancer. 2008; 98(11): 1845–51. https://doi.org/10.1038/sj.bjc.6604381</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Chatterjee D., Bhattacharjee P., Sau T.J., Das J.K., Sarma N., Bandyopadhyay A.K., et al. Arsenic exposure through drinking water leads to senescence and alteration of telomere length in humans: A case-control study in West Bengal, India. Mol. Carcinog. 2014; 54(9): 800–9. https://doi.org/10.1002/mc.22150</mixed-citation><mixed-citation xml:lang="en">Chatterjee D., Bhattacharjee P., Sau T.J., Das J.K., Sarma N., Bandyopadhyay A.K., et al. Arsenic exposure through drinking water leads to senescence and alteration of telomere length in humans: A case-control study in West Bengal, India. Mol. Carcinog. 2014; 54(9): 800–9. https://doi.org/10.1002/mc.22150</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Yih L.H., Lee T.C. Arsenite induces p53 accumulation through an ATM-dependent pathway in human fibroblasts. Cancer Res. 2000; 60(22): 6346–52.</mixed-citation><mixed-citation xml:lang="en">Yih L.H., Lee T.C. Arsenite induces p53 accumulation through an ATM-dependent pathway in human fibroblasts. Cancer Res. 2000; 60(22): 6346–52.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Taylor B.F., McNeely S.C., Miller H.L., Lehmann G.M., McCabe M.J., States J.C. p53 suppression of arsenite-induced mitotic catastrophe is mediated by p21CIP1/WAF1. J. Pharmacol. Exp. Ther. 2006; 318(1): 142–51. https://doi.org/10.1124/jpet.106.103077</mixed-citation><mixed-citation xml:lang="en">Taylor B.F., McNeely S.C., Miller H.L., Lehmann G.M., McCabe M.J., States J.C. p53 suppression of arsenite-induced mitotic catastrophe is mediated by p21CIP1/WAF1. J. Pharmacol. Exp. Ther. 2006; 318(1): 142–51. https://doi.org/10.1124/jpet.106.103077</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Vogt B.L., Rossman T.G. Effects of arsenite on p53, p21 and cyclin D expression in normal human fibroblasts – a possible mechanism for arsenite’s comutagenicity. Mutat. Res. 2001; 478(1-2): 159–68. https://doi.org/10.1016/s0027-5107(01)00137-3</mixed-citation><mixed-citation xml:lang="en">Vogt B.L., Rossman T.G. Effects of arsenite on p53, p21 and cyclin D expression in normal human fibroblasts – a possible mechanism for arsenite’s comutagenicity. Mutat. Res. 2001; 478(1-2): 159–68. https://doi.org/10.1016/s0027-5107(01)00137-3</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Komissarova E.V., Rossman T.G. Arsenite induced poly(ADPribosyl)ation of tumor suppressor P53 in human skin keratinocytes as a possible mechanism for carcinogenesis associated with arsenic exposure. Toxicol. Appl. Pharmacol. 2010; 243(3): 399–404. https://doi.org/10.1016/j.taap.2009.12.014</mixed-citation><mixed-citation xml:lang="en">Komissarova E.V., Rossman T.G. Arsenite induced poly(ADPribosyl)ation of tumor suppressor P53 in human skin keratinocytes as a possible mechanism for carcinogenesis associated with arsenic exposure. Toxicol. Appl. Pharmacol. 2010; 243(3): 399–404. https://doi.org/10.1016/j.taap.2009.12.014</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Katsiki M., Trougakos I.P., Chondrogianni N., Alexopoulos E.C., Makropoulos V., Gonos E.S. Alterations of senescence biomarkers in human cells by exposure to CrVI in vivo and in vitro. Exp. Gerontol. 2004; 39(7): 1079–87. https://doi.org/10.1016/j.exger.2004.03.039</mixed-citation><mixed-citation xml:lang="en">Katsiki M., Trougakos I.P., Chondrogianni N., Alexopoulos E.C., Makropoulos V., Gonos E.S. Alterations of senescence biomarkers in human cells by exposure to CrVI in vivo and in vitro. Exp. Gerontol. 2004; 39(7): 1079–87. https://doi.org/10.1016/j.exger.2004.03.039</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Hill R., Leidal A.M., Madureira P.A., Gillis L.D., Waisman D.M., Chiu A., et al. Chromium-mediated apoptosis: involvement of DNA-dependent protein kinase (DNA-PK) and differential induction of p53 target genes. DNA Repair (Amst.). 2008; 7(9): 1484–99. https://doi.org/10.1016/j.dnarep.2008.05.007</mixed-citation><mixed-citation xml:lang="en">Hill R., Leidal A.M., Madureira P.A., Gillis L.D., Waisman D.M., Chiu A., et al. Chromium-mediated apoptosis: involvement of DNA-dependent protein kinase (DNA-PK) and differential induction of p53 target genes. DNA Repair (Amst.). 2008; 7(9): 1484–99. https://doi.org/10.1016/j.dnarep.2008.05.007</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Choi Y.J., Yin H.Q., Suh H.R., Lee Y.J., Park S.R., Lee B.H. Involvement of E2F1 transcriptional activity in cadmium-induced cell-cycle arrest at G1 in human lung fibroblasts. Environ. Mol. Mutagen. 2011; 52(2): 145–52. https://doi.org/10.1002/em.20593</mixed-citation><mixed-citation xml:lang="en">Choi Y.J., Yin H.Q., Suh H.R., Lee Y.J., Park S.R., Lee B.H. Involvement of E2F1 transcriptional activity in cadmium-induced cell-cycle arrest at G1 in human lung fibroblasts. Environ. Mol. Mutagen. 2011; 52(2): 145–52. https://doi.org/10.1002/em.20593</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Aimola P., Carmignani M., Volpe A.R., Di Benedetto A., Claudio L., Waalkes M.P., et al. Cadmium induces p53-dependent apoptosis in human prostate epithelial cells. PLoS One. 2012; 7(3): e33647. https://doi.org/10.1371/journal.pone.0033647</mixed-citation><mixed-citation xml:lang="en">Aimola P., Carmignani M., Volpe A.R., Di Benedetto A., Claudio L., Waalkes M.P., et al. Cadmium induces p53-dependent apoptosis in human prostate epithelial cells. PLoS One. 2012; 7(3): e33647. https://doi.org/10.1371/journal.pone.0033647</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Blagus T., Zager V., Cemazar M., Sersa G., Kamensek U., Zegura B., et al. A cell-based biosensor system HepG2CDKN1A-DsRed for rapid and simple detection of genotoxic agents. Biosens. Bioelectron. 2014; 61: 102–11. https://doi.org/10.1016/j.bios.2014.05.002</mixed-citation><mixed-citation xml:lang="en">Blagus T., Zager V., Cemazar M., Sersa G., Kamensek U., Zegura B., et al. A cell-based biosensor system HepG2CDKN1A-DsRed for rapid and simple detection of genotoxic agents. Biosens. Bioelectron. 2014; 61: 102–11. https://doi.org/10.1016/j.bios.2014.05.002</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Roy R., Singh S.K., Chauhan L.K., Das M., Tripathi A., Dwivedi P.D. Zinc oxide nanoparticles induce apoptosis by enhancement of autophagy via PI3 K/Akt/mTOR inhibition. Toxicol. Lett. 2014; 227(1): 29–40. https://doi.org/10.1016/j.toxlet.2014.02.024</mixed-citation><mixed-citation xml:lang="en">Roy R., Singh S.K., Chauhan L.K., Das M., Tripathi A., Dwivedi P.D. Zinc oxide nanoparticles induce apoptosis by enhancement of autophagy via PI3 K/Akt/mTOR inhibition. Toxicol. Lett. 2014; 227(1): 29–40. https://doi.org/10.1016/j.toxlet.2014.02.024</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Satapathy S.R., Mohapatra P., Preet R., Das D., Sarkar B., Choudhuri T., et al. Silver-based nanoparticles induce apoptosis in human colon cancer cells mediated through p53. Nanomedicine (Lond.). 2013; 8(8): 1307–22. https://doi.org/10.2217/nnm.12.176</mixed-citation><mixed-citation xml:lang="en">Satapathy S.R., Mohapatra P., Preet R., Das D., Sarkar B., Choudhuri T., et al. Silver-based nanoparticles induce apoptosis in human colon cancer cells mediated through p53. Nanomedicine (Lond.). 2013; 8(8): 1307–22. https://doi.org/10.2217/nnm.12.176</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Tuomela S., Autio R., Buerki-Thurnherr T., Arslan O., Kunzmann A., Andersson-Willman B., et al. Gene expression profiling of immune-competent human cells exposed to engineered zinc oxide or titanium dioxide nanoparticles. PLoS One. 2013; 8(7): e68415. https://doi.org/10.1371/journal.pone.0068415</mixed-citation><mixed-citation xml:lang="en">Tuomela S., Autio R., Buerki-Thurnherr T., Arslan O., Kunzmann A., Andersson-Willman B., et al. Gene expression profiling of immune-competent human cells exposed to engineered zinc oxide or titanium dioxide nanoparticles. PLoS One. 2013; 8(7): e68415. https://doi.org/10.1371/journal.pone.0068415</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Srivastava R.K., Rahman Q., Kashyap M.P., Singh A.K., Jain G., Jahan S., et al. Nano-titanium dioxide induces genotoxicity and apoptosis in human lung cancer cell line, A549. Hum. Exp. Toxicol. 2013; 32(2): 153–66. https://doi.org/10.1177/0960327112462725</mixed-citation><mixed-citation xml:lang="en">Srivastava R.K., Rahman Q., Kashyap M.P., Singh A.K., Jain G., Jahan S., et al. Nano-titanium dioxide induces genotoxicity and apoptosis in human lung cancer cell line, A549. Hum. Exp. Toxicol. 2013; 32(2): 153–66. https://doi.org/10.1177/0960327112462725</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Petković J., Zegura B., Stevanović M., Drnovšek N., Uskoković D., Novak S., et al. DNA damage and alterations in expression of DNA damage responsive genes induced by TiO2 nanoparticles in human hepatoma HepG2 cells. Nanotoxicology. 2011; 5(3): 341–53. https://doi.org/10.3109/17435390.2010.507316</mixed-citation><mixed-citation xml:lang="en">Petković J., Zegura B., Stevanović M., Drnovšek N., Uskoković D., Novak S., et al. DNA damage and alterations in expression of DNA damage responsive genes induced by TiO2 nanoparticles in human hepatoma HepG2 cells. Nanotoxicology. 2011; 5(3): 341–53. https://doi.org/10.3109/17435390.2010.507316</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Kang S.J., Kim B.M., Lee Y.J., Chung H.W. Titanium dioxide nanoparticles trigger p53-mediated damage response in peripheral blood lymphocytes. Environ. Mol. Mutagen. 2008; 49(5): 399–405. https://doi.org/10.1002/em.20399</mixed-citation><mixed-citation xml:lang="en">Kang S.J., Kim B.M., Lee Y.J., Chung H.W. Titanium dioxide nanoparticles trigger p53-mediated damage response in peripheral blood lymphocytes. Environ. Mol. Mutagen. 2008; 49(5): 399–405. https://doi.org/10.1002/em.20399</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Wu J., Sun J. Investigation on mechanism of growth arrest induced by iron oxide nanoparticles in PC12 cells. J. Nanosci. Nanotechnol. 2011; 11(12): 11079–83. https://doi.org/10.1166/jnn.2011.3948</mixed-citation><mixed-citation xml:lang="en">Wu J., Sun J. Investigation on mechanism of growth arrest induced by iron oxide nanoparticles in PC12 cells. J. Nanosci. Nanotechnol. 2011; 11(12): 11079–83. https://doi.org/10.1166/jnn.2011.3948</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Liao M.Y., Liu H.G. Gene expression profiling of nephrotoxicity from copper nanoparticles in rats after repeated oral administration. Environ. Toxicol. Pharmacol. 2012; 34(1): 67–80. https://doi.org/10.1016/j.etap.2011.05.014</mixed-citation><mixed-citation xml:lang="en">Liao M.Y., Liu H.G. Gene expression profiling of nephrotoxicity from copper nanoparticles in rats after repeated oral administration. Environ. Toxicol. Pharmacol. 2012; 34(1): 67–80. https://doi.org/10.1016/j.etap.2011.05.014</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Mendoza M., Mandani G., Momand J. The MDM2 gene family. Biomol. Concepts. 2013; 5(1): 9–19. https://doi.org/10.1515/bmc-2013-0027</mixed-citation><mixed-citation xml:lang="en">Mendoza M., Mandani G., Momand J. The MDM2 gene family. Biomol. Concepts. 2013; 5(1): 9–19. https://doi.org/10.1515/bmc-2013-0027</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Ellinger-Ziegelbauer H., Stuart B., Wahle B., Bomann W., Ahr H.J. Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver. Mutat. Res. 2005; 575(1–2): 61–84. https://doi.org/10.1016/j.mrfmmm.2005.02.004</mixed-citation><mixed-citation xml:lang="en">Ellinger-Ziegelbauer H., Stuart B., Wahle B., Bomann W., Ahr H.J. Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver. Mutat. Res. 2005; 575(1–2): 61–84. https://doi.org/10.1016/j.mrfmmm.2005.02.004</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Deng H., Ikeda A., Cui H., Bartlett J.D., Suzuki M. MDM2-mediated p21 proteasomal degradation promotes fluoride toxicity in ameloblasts. Cells. 2019; 8(5): 436. https://doi.org/10.3390/cells8050436</mixed-citation><mixed-citation xml:lang="en">Deng H., Ikeda A., Cui H., Bartlett J.D., Suzuki M. MDM2-mediated p21 proteasomal degradation promotes fluoride toxicity in ameloblasts. Cells. 2019; 8(5): 436. https://doi.org/10.3390/cells8050436</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Liu H., Deng H., Jian Z., Cui H., Guo H., Fang J., et al. Copper exposure induces hepatic G0/G1 cell-cycle arrest through suppressing the Ras/PI3K/Akt signaling pathway in mice. Ecotoxicol. Environ. Saf. 2021; 222: 112518. https://doi.org/10.1016/j.ecoenv.2021.112518</mixed-citation><mixed-citation xml:lang="en">Liu H., Deng H., Jian Z., Cui H., Guo H., Fang J., et al. Copper exposure induces hepatic G0/G1 cell-cycle arrest through suppressing the Ras/PI3K/Akt signaling pathway in mice. Ecotoxicol. Environ. Saf. 2021; 222: 112518. https://doi.org/10.1016/j.ecoenv.2021.112518</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Lee J.Y., Tokumoto M., Fujiwara Y., Hasegawa T., Seko Y., Shimada A., et al. Accumulation of p53 via down-regulation of UBE2D family genes is a critical pathway for cadmium-induced renal toxicity. Sci. Rep. 2016; 6: 21968. https://doi.org/10.1038/srep21968</mixed-citation><mixed-citation xml:lang="en">Lee J.Y., Tokumoto M., Fujiwara Y., Hasegawa T., Seko Y., Shimada A., et al. Accumulation of p53 via down-regulation of UBE2D family genes is a critical pathway for cadmium-induced renal toxicity. Sci. Rep. 2016; 6: 21968. https://doi.org/10.1038/srep21968</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Alkharashi N.A.O., Periasamy V.S., Athinarayanan J., Alshatwi A.A. Sulforaphane alleviates cadmium-induced toxicity in human mesenchymal stem cells through POR and TNFSF10 genes expression. Biomed. Pharmacother. 2019; 115: 108896. https://doi.org/10.1016/j.biopha.2019.108896</mixed-citation><mixed-citation xml:lang="en">Alkharashi N.A.O., Periasamy V.S., Athinarayanan J., Alshatwi A.A. Sulforaphane alleviates cadmium-induced toxicity in human mesenchymal stem cells through POR and TNFSF10 genes expression. Biomed. Pharmacother. 2019; 115: 108896. https://doi.org/10.1016/j.biopha.2019.108896</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Strauch B.M., Niemand R.K., Winkelbeiner N.L., Hartwig A. Comparison between micro- and nanosized copper oxide and water soluble copper chloride: interrelationship between intracellular copper concentrations, oxidative stress and DNA damage response in human lung cells. Part. Fibre Toxicol. 2017; 14(1): 28. https://doi.org/10.1186/s12989-017-0209-1</mixed-citation><mixed-citation xml:lang="en">Strauch B.M., Niemand R.K., Winkelbeiner N.L., Hartwig A. Comparison between micro- and nanosized copper oxide and water soluble copper chloride: interrelationship between intracellular copper concentrations, oxidative stress and DNA damage response in human lung cells. Part. Fibre Toxicol. 2017; 14(1): 28. https://doi.org/10.1186/s12989-017-0209-1</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Petković J., Zegura B., Stevanović M., Drnovšek N., Uskoković D., Novak S., et al. DNA damage and alterations in expression of DNA damage responsive genes induced by TiO2 nanoparticles in human hepatoma HepG2 cells. Nanotoxicology. 2011; 5(3): 341–53. https://doi.org/10.3109/17435390.2010.507316</mixed-citation><mixed-citation xml:lang="en">Petković J., Zegura B., Stevanović M., Drnovšek N., Uskoković D., Novak S., et al. DNA damage and alterations in expression of DNA damage responsive genes induced by TiO2 nanoparticles in human hepatoma HepG2 cells. Nanotoxicology. 2011; 5(3): 341–53. https://doi.org/10.3109/17435390.2010.507316</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Chen F.C., Huang C.M., Yu X.W., Chen Y.Y. Effect of nano zinc oxide on proliferation and toxicity of human gingival cells. Hum. Exp. Toxicol. 2022; 41: 9603271221080236. https://doi.org/10.1177/09603271221080237</mixed-citation><mixed-citation xml:lang="en">Chen F.C., Huang C.M., Yu X.W., Chen Y.Y. Effect of nano zinc oxide on proliferation and toxicity of human gingival cells. Hum. Exp. Toxicol. 2022; 41: 9603271221080236. https://doi.org/10.1177/09603271221080237</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Kim M.H., Jeong H.J. Zinc oxide nanoparticles demoted MDM2 expression to suppress TSLP-induced mast cell proliferation. J. Nanosci. Nanotechnol. 2016; 16(3): 2492–8. https://doi.org/10.1166/jnn.2016.10785</mixed-citation><mixed-citation xml:lang="en">Kim M.H., Jeong H.J. Zinc oxide nanoparticles demoted MDM2 expression to suppress TSLP-induced mast cell proliferation. J. Nanosci. Nanotechnol. 2016; 16(3): 2492–8. https://doi.org/10.1166/jnn.2016.10785</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Uziel T., Savitsky K., Platzer M., Ziv Y., Helbitz T., Nehls M., et al. Genomic organization of the ATM gene. Genomics. 1996; 33(2): 317–20. https://doi.org/10.1006/geno.1996.0201</mixed-citation><mixed-citation xml:lang="en">Uziel T., Savitsky K., Platzer M., Ziv Y., Helbitz T., Nehls M., et al. Genomic organization of the ATM gene. Genomics. 1996; 33(2): 317–20. https://doi.org/10.1006/geno.1996.0201</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Khanna K.K., Jackson S.P. DNA double-strand breaks: signalling, repair and the cancer connection. Nat. Genet. 2001; 27(3): 247–54. https://doi.org/10.1038/85798</mixed-citation><mixed-citation xml:lang="en">Khanna K.K., Jackson S.P. DNA double-strand breaks: signalling, repair and the cancer connection. Nat. Genet. 2001; 27(3): 247–54. https://doi.org/10.1038/85798</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Kim S.T., Lim D.S., Canman C.E., Kastan M.B. Substrate specificities and identification of putative substrates of ATM kinase family members. J. Biol. Chem. 1999; 274(53): 37538–43. https://doi.org/10.1074/jbc.274.53.37538</mixed-citation><mixed-citation xml:lang="en">Kim S.T., Lim D.S., Canman C.E., Kastan M.B. Substrate specificities and identification of putative substrates of ATM kinase family members. J. Biol. Chem. 1999; 274(53): 37538–43. https://doi.org/10.1074/jbc.274.53.37538</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">O’Neill T., Dwyer A.J., Ziv Y., Chan D.W., Lees-Miller S.P., Abraham R.H., et al. Utilization of oriented peptide libraries to identify substrate motifs selected by ATM. J. Biol. Chem. 2000; 275(30): 22719–27. https://doi.org/10.1074/jbc.m001002200</mixed-citation><mixed-citation xml:lang="en">O’Neill T., Dwyer A.J., Ziv Y., Chan D.W., Lees-Miller S.P., Abraham R.H., et al. Utilization of oriented peptide libraries to identify substrate motifs selected by ATM. J. Biol. Chem. 2000; 275(30): 22719–27. https://doi.org/10.1074/jbc.m001002200</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Kastan M.B., Lim D.S. The many substrates and functions of ATM. Nat. Rev. Mol. Cell Biol. 2000; 1(3): 179–86. https://doi.org/10.1038/35043058</mixed-citation><mixed-citation xml:lang="en">Kastan M.B., Lim D.S. The many substrates and functions of ATM. Nat. Rev. Mol. Cell Biol. 2000; 1(3): 179–86. https://doi.org/10.1038/35043058</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Jin M.H., Oh D.Y. ATM in DNA repair in cancer. Pharmacol. Ther. 2019; 203: 107391. https://doi.org/10.1016/j.pharmthera.2019.07.002</mixed-citation><mixed-citation xml:lang="en">Jin M.H., Oh D.Y. ATM in DNA repair in cancer. Pharmacol. Ther. 2019; 203: 107391. https://doi.org/10.1016/j.pharmthera.2019.07.002</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Barlow C., Hirotsune S., Paylor R., Liyanage M., Eckhaus M., Collins F., et al. Atm-deficient mice: a paradigm of ataxia-telangiectasia. Cell. 1996; 86(1): 159–71. https://doi.org/10.1016/s0092-8674(00)80086-0</mixed-citation><mixed-citation xml:lang="en">Barlow C., Hirotsune S., Paylor R., Liyanage M., Eckhaus M., Collins F., et al. Atm-deficient mice: a paradigm of ataxia-telangiectasia. Cell. 1996; 86(1): 159–71. https://doi.org/10.1016/s0092-8674(00)80086-0</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Xu Y., Ashley T., Brainerd E.E., Bronson R.T., Meyn S.M., Baltimore D. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects and thymic lymphoma. Genes Dev. 1996; 10(19): 2411–22. https://doi.org/10.1101/gad.10.19.2411</mixed-citation><mixed-citation xml:lang="en">Xu Y., Ashley T., Brainerd E.E., Bronson R.T., Meyn S.M., Baltimore D. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects and thymic lymphoma. Genes Dev. 1996; 10(19): 2411–22. https://doi.org/10.1101/gad.10.19.2411</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Taylor A.M., Metcalfe J.A., Thick J., Mak Y.F. Leukemia and lymphoma in ataxia telangiectasia. Blood. 1996; 87(2): 423–38.</mixed-citation><mixed-citation xml:lang="en">Taylor A.M., Metcalfe J.A., Thick J., Mak Y.F. Leukemia and lymphoma in ataxia telangiectasia. Blood. 1996; 87(2): 423–38.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Alves M.G.O., Carta C.F.L., de Barros P.P., Issa J.S., Nunes F.D., Almeida J.D. Repair genes expression profile of MLH1, MSH2 and ATM in the normal oral mucosa of chronic smokers. Arch. Oral Biol. 2017; 73: 60–5. https://doi.org/10.1016/j.archoralbio.2016.09.006</mixed-citation><mixed-citation xml:lang="en">Alves M.G.O., Carta C.F.L., de Barros P.P., Issa J.S., Nunes F.D., Almeida J.D. Repair genes expression profile of MLH1, MSH2 and ATM in the normal oral mucosa of chronic smokers. Arch. Oral Biol. 2017; 73: 60–5. https://doi.org/10.1016/j.archoralbio.2016.09.006</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Morimoto H., Tsukada J., Kominato Y., Tanaka Y. Reduced expression of human mismatch repair genes in adult T-cell leukemia. Am. J. Hematol. 2005; 78(2): 100–7. https://doi.org/10.1002/ajh.20259</mixed-citation><mixed-citation xml:lang="en">Morimoto H., Tsukada J., Kominato Y., Tanaka Y. Reduced expression of human mismatch repair genes in adult T-cell leukemia. Am. J. Hematol. 2005; 78(2): 100–7. https://doi.org/10.1002/ajh.20259</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Asare N., Duale N., Slagsvold H.H., Lindeman B., Olsen A.K., Gromadzka-Ostrowska J., et al. Genotoxicity and gene expression modulation of silver and titanium dioxide nanoparticles in mice. Nanotoxicology. 2015; 10(3): 312–21. https://doi.org/10.3109/17435390.2015.1071443</mixed-citation><mixed-citation xml:lang="en">Asare N., Duale N., Slagsvold H.H., Lindeman B., Olsen A.K., Gromadzka-Ostrowska J., et al. Genotoxicity and gene expression modulation of silver and titanium dioxide nanoparticles in mice. Nanotoxicology. 2015; 10(3): 312–21. https://doi.org/10.3109/17435390.2015.1071443</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Muenyi C.S., Ljungman M., States J.C. Arsenic disruption of DNA damage responses-potential role in carcinogenesis and chemotherapy. Biomolecules. 2015; 5(4): 2184–93. https://doi.org/10.3390/biom5042184</mixed-citation><mixed-citation xml:lang="en">Muenyi C.S., Ljungman M., States J.C. Arsenic disruption of DNA damage responses-potential role in carcinogenesis and chemotherapy. Biomolecules. 2015; 5(4): 2184–93. https://doi.org/10.3390/biom5042184</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
